Thus, HMGB1 triggered the downstream inflammation pathway without changing the levels of its receptors, highlighting the crucial role of HMGB1 in the VCI pathophysiology induced by CCH. This evidence concerns the gene HMGB1 and columnar cell hyperplasia of the breast.